PT Sarimelati Kencana Tbk (PZZA)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 164.00 |
|---|---|
| 52-week range | 150.00 – 273.65 |
| Return, 1 month / 3 months | −12.8% / −12.3% |
| Return, 1 year / 3 years | −35.9% / −62.2% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 38.0% |
| Worst drawdown (1 year) | -38.7% |
| Average daily value traded | 315.45M IDR |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PT Sarimelati Kencana Tbk runs the Pizza Hut restaurant business in Indonesia. The company operates dine-in Pizza Hut outlets and delivery-focused Pizza Hut Delivery stores, serving pizzas, pasta, side dishes and drinks to families and casual diners in cities across the country. It works under a franchise arrangement with the international Pizza Hut brand owner and is based in Indonesia, where its restaurants form its main business.
The shares are listed on the Jakarta Exchange in Indonesia under the code PZZA, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PT Sarimelati Kencana Tbk (PZZA) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 164.00 on 19 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 475 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.9% and over the last three months it fell 12.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -16.0% | ||
| From 52-week high | -38.7% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.3% | ||
| 6-month return | -24.1% | ||
| 12-month return, skipping the last month | -26.5% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.7% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 315.45M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 15 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −11.8% |
|---|---|
| 1 month | −12.8% |
| 3 months | −12.3% |
| 6 months | −24.1% |
| 1 year | −35.9% |
| 3 years | −62.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 184.56 / 195.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | IDR 1.6600 |
| 31 May 2022 | IDR 19.9635 |
| 2 Jun 2021 | IDR 21.9598 |
| 26 Jun 2020 | IDR 29.9500 |
| 6 May 2019 | IDR 28.6400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.